Phathom Pharmaceuticals (PHAT) Depreciation and Depletion (2019 - 2023)

Phathom Pharmaceuticals (PHAT) has 5 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q3 2023.

• On a quarterly basis, Depreciation and Depletion fell 50.0% year-over-year to $100000.0 in Q3 2023; TTM through Sep 2023 was $400000.0, a 22.18% decrease from a year earlier, with the FY2022 full-year figure at $600000.0, up 20.0% from the prior year.
• Depreciation and Depletion for Q3 2023 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for PHAT reached as high as $200000.0 in Q3 2022 and fell as low as $2000.0 in Q3 2019.
• Historically, Depreciation and Depletion has averaged $94588.2 across 5 years, with a median of $100000.0 in 2022.
• Across the five-year window, Depreciation and Depletion soared 4300.0% in 2020 and slumped 50.0% in 2023, its largest moves.
• Year by year, Depreciation and Depletion stood at $6000.0 in 2019, then surged by 1283.33% to $83000.0 in 2020, then jumped by 37.35% to $114000.0 in 2021, then retreated by 12.28% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $100000.0 in Q3 2023, $100000.0 in Q2 2023, and $100000.0 in Q1 2023.